INO:NASDAQ
Inovio Pharmaceuticals Inc
1,43 USD
0,00%
(0,00) 1D
1,40 USD
arrow_downward
-1,90% (-0,027)todayPre-market
Closed: 13-ноя., 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Mkt. cap
267,85 млн
Avg. vol.
19,34 млн
Volume
77,20 миң
52-wk high
2,72 USD
52-wk low
0,56 USD
EPS
-0,80 USD
Beta
1,71
Shares outstanding
187,31 млн
No. of employees
112
Mkt. cap
267,85 млн
Avg. vol.
19,34 млн
Volume
77,20 миң
52-wk high
2,72 USD
52-wk low
0,56 USD
EPS
-0,80 USD
Beta
1,71
Shares outstanding
187,31 млн
No. of employees
112
News stories
From web sources and news partners
Yahoo Finance
·
35 мүнөт мурун
Nearly a fifth of the S&P 500 is tied to three men with no clear successors
Investing.com
·
41 мүнөт мурун
Dow Jones, Nasdaq, S&P 500 weekly preview: Nvidia earnings, Anthropic IPO on deck
Business Insider
·
3 саат мурун
A veteran strategist sees a split in the stock market leading to a 15% drop in the S&P 500
FXEmpire
·
22 мүнөт мурун
Why The S&P 500 Could Fall 63% – And Still Only Be Fairly Valued
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc